Showing results (71-80 of 161) with videos related to
Sort By:
Pageof 17
Molecular Cancer Research : MCR|February 23, 2017
Dysregulated GPCR Signaling and Therapeutic Options in Uveal MelanomaVivian Chua, Dominic Lapadula, Clinita Randolph, et al.Cancers|April 3, 2021
Dual Targeting of CDK4/6 and cMET in Metastatic Uveal MelanomaMasahiro Ohara, Kengo Saito, Ken Kageyama, et al.Journal of Virology|August 4, 2019
Murine Cytomegalovirus Infection of Melanoma Lesions Delays Tumor Growth by Recruiting and Repolarizing Monocytic Phagocytes in the TumorNicole A Wilski, Christina Del Casale, Timothy J Purwin, et al.Oncogene|March 1, 2005
Adhesion control of cyclin D1 and p27Kip1 levels is deregulated in melanoma cells through BRAF-MEK-ERK signalingKavita V Bhatt, Laurie S Spofford, Gazelle Aram, et al.Cancer Research|October 15, 2013
In vivo MAPK reporting reveals the heterogeneity in tumoral selection of resistance to RAF inhibitorsKevin J Basile, Ethan V Abel, Neda Dadpey, et al.Cancer Research|May 9, 2015
Paracrine Effect of NRG1 and HGF Drives Resistance to MEK Inhibitors in Metastatic Uveal MelanomaHanyin Cheng, Mizue Terai, Ken Kageyama, et al.Pigment Cell & Melanoma Research|November 8, 2019
PLX3397 inhibits the accumulation of intra-tumoral macrophages and improves bromodomain and extra-terminal inhibitor efficacy in melanomaDan A Erkes, Sheera R Rosenbaum, Conroy O Field, et al.Nature Communications|April 13, 2019
Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activationCorey Rogers, Dan A Erkes, Alexandria Nardone, et al.The Journal of Biological Chemistry|October 19, 2012
SHOC2 and CRAF mediate ERK1/2 reactivation in mutant NRAS-mediated resistance to RAF inhibitorFred M Kaplan, Curtis H Kugel, Neda Dadpey, et al.Journal of Translational Medicine|May 22, 2020
Development and optimization of orthotopic liver metastasis xenograft mouse models in uveal melanomaTakahito Sugase, Bao Q Lam, Meggie Danielson, et al.Pageof 17